Ubiltuximab- Xe129 -(XENOVIEN)- (Dec 2022) - to treat relapsing forms of multiple scalerosis

Drug Name:
Ubiltuximab- Xe129 -(XENOVIEN)- (Dec 2022) - to treat relapsing forms of multiple scalerosis

List Of Brands:

Indication Type Description:

Indication

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation